Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.

Byrd J C;Brown J R;OBrien S;Barrientos J C;Kay N E;Reddy N M;Coutre S;Tam C S;Mulligan S P;Jaeger U;Devereux D;Barr P M;Furman R R;Kipps T J;Cymbalista F;Pocock C;Thorton P;Caligaris Cappio F;Robak T;Delgado J;Schuster S J;Montillo M;Schun A;de Vos S;Gill D;Bloor A;Dearden C;Moreno C;Jones J J;Chu A D;Fardis M;McGreivy J;Clow F;James D F;Hillmen P;Santoro A

2014-01-01